• DMH1: Selective BMP Type I Receptor Inhibitor for Organoi...

  2025-10-22

  DMH1 empowers researchers to selectively modulate BMP signaling in organoid engineering and non-small cell lung cancer models, driving breakthroughs in cell fate control and tumor suppression. Its robust specificity for ALK2 and ALK3 ensures reproducible, high-throughput experimental outcomes while minimizing off-target effects. Discover protocol optimizations, comparative insights, and troubleshooting strategies to maximize DMH1's impact in applied biomedical workflows.

• Torin2: Selective mTOR Inhibitor Workflows for Cancer Res...

  2025-10-21

  Torin2, a highly selective and cell-permeable mTOR inhibitor, is transforming cancer research by enabling precise dissection of PI3K/Akt/mTOR signaling and apoptosis beyond transcriptional regulation. This guide delivers proven experimental workflows, advanced applications, and troubleshooting strategies for maximizing Torin2’s impact in cellular and in vivo models.

77 records 6/6 page Previous First page 上5页 6